Literature DB >> 31739945

Radiation Therapy for Benign Disease: Arteriovenous Malformations, Desmoid Tumor, Dupuytren Contracture, Graves Ophthalmopathy, Gynecomastia, Heterotopic Ossification, Histiocytosis.

Tony Y Eng1, Mustafa Abugideiri2, Tiffany W Chen3, Nicholas Madden2, Tiffany Morgan2, Daniel Tanenbaum2, Narine Wandrey3, Sarah Westergaard2, Karen Xu2, Lisa Jane Sudmeier2.   

Abstract

Although the use of ionizing radiation in malignant conditions has been well established, its application in benign conditions has not been fully accepted and has been inadequately recognized by health care providers outside of radiation therapy. Most frequently, radiation therapy in these benign conditions is used along with other treatment modalities, such as surgery, in instances where the condition causes significant disability or could even lead to death. Radiation therapy can be helpful for inflammatory/proliferative disorders. This article discusses the current use of radiation therapy in some of the more common benign conditions.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arteriovenous malformations; Benign disease; Desmoid tumor; Dupuytren contracture; Graves ophthalmopathy; Gynecomastia; Heterotopic ossification; Histiocytosis; Radiation therapy

Mesh:

Year:  2019        PMID: 31739945     DOI: 10.1016/j.hoc.2019.09.005

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  1 in total

1.  Adjuvant Radiation after Primary Resection of Atypical Lipomatous Tumors of the Extremity Reduces Local Recurrence but Increases Complications: A Multicenter Evaluation.

Authors:  Joshua M Lawrenz; Samuel R Johnson; Kevin Zhu; Mallory McKeon; Cullen P Moran; Jose Vega; Katherine S Hajdu; James P Norris; Leo Y Luo; Eric T Shinohara; Justin M M Cates; Brian P Rubin; John D Reith; Jennifer L Halpern; Nathan W Mesko; Herbert S Schwartz; Lukas M Nystrom; Ginger E Holt
Journal:  Sarcoma       Date:  2022-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.